6533b7d2fe1ef96bd125eb3d

RESEARCH PRODUCT

Lipid peroxidation as measured by chromatographic determination of malondialdehyde. Human plasma reference values in health and disease

Jose ViñaConsuelo BorrasCristina Mas-barguesConsuelo EscriváMar Dromant

subject

0301 basic medicineBiophysicsDiseasemedicine.disease_causeBiochemistryLipid peroxidationPulmonary Disease Chronic Obstructive03 medical and health scienceschemistry.chemical_compoundReference ValuesMalondialdehydePhysiology (medical)Diabetes MellitusmedicineHumansExerciseMolecular BiologyChromatography High Pressure Liquidchemistry.chemical_classificationChromatographyFrailty030102 biochemistry & molecular biologyAge FactorsNeurodegenerative DiseasesMalondialdehydeOxidative Stress030104 developmental biologyBiochemistrychemistryHuman plasmaReference valuesBiomarker (medicine)Kidney DiseasesLipid PeroxidationSignal transductionBiomarkersOxidative stressPolyunsaturated fatty acid

description

Free radicals and oxidants are involved in physiological signaling pathways, although an imbalance between pro-oxidant and anti-oxidant systems in favor of the former leads to major biomolecular damage. This is the so-called oxidative stress, a complex process that affects us all and is responsible for the development of many diseases. Lipids are very sensitive to oxidant attack and to-date, malondialdehyde (MDA), 4-hydroxy-2-nonenal (4-HNE) and F2-isoprostane are the main biomarkers for lipid peroxidation assessment. They all derive from polyunsaturated fatty acids (PUFAs) either by enzyme-catalyzed reactions (physiological) or by non-enzyme reactions (pathological). The profile of PUFAs present in the tissue will determine the proportion of each biomarker. In this review we aim to discuss the proper method for MDA determination using HPLC. We also offer reference MDA values in humans in physiological and pathological conditions.

https://doi.org/10.1016/j.freeradbiomed.2020.12.325